2020/5/27 15:48:00
Drugs and medical devices have played an important role in the prevention and control of the new coronary pneumonia epidemic as a special product for the treatment and rescue of people. "Strengthening the guarantee of emergency supplies" was included in this year's government work report. At the third meeting of the 13th National Committee of the Chinese People's Political Consultative Conference, Jiao Hong, member of the Standing Committee of the Chinese People's Political Consultative Conference, vice chairman of the Central Committee of the Agricultural and Labor Party, and director of the State Drug Administration, proposed to take the opportunity of prevention and control of the new coronary pneumonia epidemic as an opportunity to further strengthen the construction of an emergency management system for pharmaceutical and medical devices and improve The major epidemic prevention and control system will effectively improve the ability and level of responding to major public health emergencies.
"The current epidemic prevention and control blockade battle has achieved major strategic results, and overall efforts have been made to promote the epidemic prevention and control and economic and social development to achieve positive results. But at the same time, it should also be recognized that there are still shortcomings in emergency research and development, medical protection materials protection, and departmental cooperation To this end, Commissioner Jiao Hong suggested that taking the prevention and control of epidemic situations as an opportunity to further consolidate the foundation of the rule of law for emergency management of drugs and medical devices. The effective practices and good experience in the prevention and control of the epidemic will be consolidated in the form of laws and regulations, and a legal system for emergency management of pharmaceutical and medical devices with a complete system, interconnection and operation will be built. Study and formulate China's emergency system for the use of drugs and medical devices, and refine the corresponding process. Further improve the emergency approval system for drugs and medical devices rated as early intervention, research and review linkage, follow-up and review, and scientific review, so as to realize the scientific overall consideration of ensuring the safety and effectiveness of drugs and medical devices and the urgent needs of epidemic prevention and control.
In order to effectively guarantee the research and development, production and supply of medicines and medical devices needed for responding to major public health emergencies, Committee member Jiao Hong proposed to actively build a national medicine and medical device emergency platform with scientific authority, unified command, efficient operation and strong guarantee. The platform should strengthen multi-party collaboration and be led by relevant departments such as science and technology, health, and drug supervision. It integrates emergency research and development, inspection and testing, review and approval, production and supply, treatment and use, monitoring and evaluation of drugs and medical devices, and incorporates high-level technology The team and the powerful R & D team and its cooperative enterprises focus on the strengths of all parties to strengthen interaction and coordinate advancement to ensure that safe and effective medical equipment is put into clinical use as quickly as possible. Improve the platform ’s decision-making mechanism, information sharing and release mechanism, expert consultation mechanism, etc. during major public health emergencies to ensure the platform ’s physical operation in an emergency.
Commissioner Jiao Hong also suggested that we should actively improve the emergency support system for pharmaceutical and medical devices. Scientific planning is based on the emergency material reserve system to respond to major public health emergencies, increase support for basic scientific research related to drugs and medical devices, strengthen cutting-edge technology reserves, and strengthen the capacity building of technical units such as national inspection and testing, review and approval, Support enterprise R & D and innovation, master key core technologies; support front-line technical innovation in epidemic prevention and control and emergency treatment, and improve research capabilities in wartime research. In terms of talent construction, increase the cultivation of innovative leaders in the pharmaceutical industry, improve the effective coordination mechanism of scientific research institutes, leading enterprises, medical institutions, and government agencies, accelerate the construction of a team of professional and professional inspectors and reviewers, and increase the high level The introduction of professional and technical personnel will unblock the career development channel of professional and technical personnel. At the same time, we must actively participate in the international affairs of pharmaceutical equipment, fully participate in the affairs of international organizations such as the World Health Organization, deepen the cooperation and exchanges with drug regulatory agencies of various countries, and actively carry out international scientific research cooperation in response to major public health emergencies. Share key information with other parties to comprehensively improve response capabilities.
(From admin)
Medical-in-China
Balan-Expo
